000 01735 a2200517 4500
005 20250513203834.0
264 0 _c20000315
008 200003s 0 0 eng d
022 _a0270-9139
024 7 _a10.1002/hep.510310314
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNagler, A
245 0 0 _aOral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cMar 2000
300 _a641-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAutoimmunity
650 0 4 _aCell Transplantation
650 0 4 _aChronic Disease
650 0 4 _aCollagen
_xgenetics
650 0 4 _aFemale
650 0 4 _aGraft vs Host Disease
_xblood
650 0 4 _aIn Situ Hybridization
650 0 4 _aInterferon-gamma
_xblood
650 0 4 _aInterleukin-10
_xblood
650 0 4 _aInterleukin-2
_xblood
650 0 4 _aLiver Diseases
_xcomplications
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aProteins
_xadministration & dosage
650 0 4 _aSpleen
_xcytology
650 0 4 _aTumor Necrosis Factor-alpha
_xanalysis
700 1 _aPines, M
700 1 _aAbadi, U
700 1 _aPappo, O
700 1 _aZeira, M
700 1 _aRabbani, E
700 1 _aEngelhardt, D
700 1 _aOhana, M
700 1 _aChowdhury, N R
700 1 _aChowdhury, J R
700 1 _aIlan, Y
773 0 _tHepatology (Baltimore, Md.)
_gvol. 31
_gno. 3
_gp. 641-8
856 4 0 _uhttps://doi.org/10.1002/hep.510310314
_zAvailable from publisher's website
999 _c10660588
_d10660588